Nasal Glucagon Approved for Severe Hypoglycemia

被引：2
|
作者：
Voelker, Rebecca
机构：
来源：
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2019年 / 322卷 / 09期
关键词：
D O I：
10.1001/jama.2019.12938
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：807 / 807
页数：1
相关论文
共 50 条
  • [1] Generic Glucagon Approved for Severe Hypoglycemia
    Jaklevic, Mary Chris
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2021, 325 (07): : 613 - 613
  • [2] Glucagon Nasal Powder (Baqsimi) for Severe Hypoglycemia
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2019, 61 (1581): : 148 - 149
  • [3] NASAL GLUCAGON: A NOVEL RESCUE OPTION FOR SEVERE HYPOGLYCEMIA
    Sherr, J.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2020, 22 : A14 - A14
  • [4] THE TECHNOLOGY BEHIND NASAL GLUCAGON DELIVERY FOR THE RESCUE OF SEVERE HYPOGLYCEMIA
    Pack, B.
    Allen, R.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2021, 23 : A165 - A166
  • [5] Cost of Severe Hypoglycemia and Budget Impact with Nasal Glucagon in Patients with Diabetes in Spain
    Beatrice Osumili
    Esther Artime
    Beth Mitchell
    Miriam Rubio-de Santos
    Silvia Díaz-Cerezo
    Marga Giménez
    Erik Spaepen
    Helen Sharland
    William J. Valentine
    Diabetes Therapy, 2022, 13 : 775 - 794
  • [6] Cost of Severe Hypoglycemia and Budget Impact with Nasal Glucagon in Patients with Diabetes in Spain
    Osumili, Beatrice
    Artime, Esther
    Mitchell, Beth
    Rubio-de Santos, Miriam
    Diaz-Cerezo, Silvia
    Gimenez, Marga
    Spaepen, Erik
    Sharland, Helen
    Valentine, William J.
    DIABETES THERAPY, 2022, 13 (04) : 775 - 794
  • [7] NASAL VERSUS INJECTED GLUCAGON: USER EXPERIENCE RESULTS OF A SIMULATED SEVERE HYPOGLYCEMIA STUDY
    Child, C.
    Gerety, G.
    Bajpai, S.
    Spaepen, E.
    Suico, J.
    Settles, J.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2020, 22 : A54 - A54
  • [8] INDIRECT TREATMENT COMPARISON OF READY-TO-USE GLUCAGON RESCUE TREATMENTS FOR SEVERE HYPOGLYCEMIA: NASAL GLUCAGON VERSUS LIQUID STABLE GLUCAGON
    Yan, Y.
    Child, C.
    Syring, K.
    Wang, Q.
    Threlkeld, R.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2022, 24 : A49 - A50
  • [9] Studying the Impact of Nasal Glucagon on Real-Life Experiences of Severe Hypoglycemia Treatment (SIMPLEST)
    Mitchell, Beth
    Ponce-Ibarra, Alfonso
    Moennig, Elisabeth
    Odak, Shardul
    Mcsorley, David J.
    Spaepen, Erik
    Jackson, Laurin
    Yan, Yu
    DIABETES, 2023, 72
  • [10] Nasal vs. Injected Glucagon: User Experience Results of a Simulated Severe Hypoglycemia Study
    Settles, Julie
    Child, Christopher J.
    Bajpai, Sanjay K.
    Spaepen, Erik
    Suico, Jeffrey G.
    DIABETES, 2019, 68
12345